Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs MediRX

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and MediRX head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 291 · Grade C

MediRX

Visit MediRX Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 64 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make MediRX a bad call — it's best for people comparing injection and oral treatment who confirm the full prescription quote, clinical assignment and written cancellation terms. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
36
Supply Reliability
95
75
Transparency
90
72
Access Breadth
93
56
Clinical Oversight
92
82
Track Record
88
73
CoreAge RxBrief Score 94 · 64MediRX

Price, coverage & the tracker

CoreAge RxMediRX
Brief Score94/100 (A)64/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Injection from $149

Oral tablets from $249; full supply and renewal quote unknown.

Medication and delivery advertised included; cancellation notice 72 hours.

Full price details

Compounded semaglutide injection and oral options listed; complete selected-prescription quote unknown; main offer injection from $149, oral tablets from $249 without established full supply period or renewal charge

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Injection from $199

Oral tablets from $279; full supply and renewal quote unknown.

Medication and delivery advertised included; cancellation notice 72 hours.

Full price details

Compounded tirzepatide injection and oral options listed; complete selected-prescription quote unknown; main offer injection from $199, oral tablets from $279 without established full supply period or renewal charge

CoverageUS only; restrictions by state, confirmed at intakeTerms advertise all 50 states plus DC; clinician licensing, pharmacy eligibility and required live visits still depend on patient location.
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

MediRX: MediRX lists injection and oral options without membership fees, but the full supply price and its overlapping refund cutoffs need confirmation.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.